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ABSTRACT
Objective: Labor induction by medication is now preferred by many obstetricians. The impact of induction remains ambiguous, although many 
studies and systematic reviews have been conducted. Few studies have reported for its better outcomes while other studies with poor outcomes. The 
objective of the study is to identify the common indications of induction and the risk of cesarean section after induction.
Methods: Various standardized databases, such as Pub Med, Scopus, and Google Scholar, were used to collect the scientific studies, where prostaglandin 
was used as drug of choice for induction of labor. The key words used were induction of labor, indications of induction, induction by misoprostol, 
induction and risk of cesarean section, etc. The survey spans over 22 years of study articles published from the year 1995-2017.
Result: A total of 112 studies have been included to analyze the indications and risk of cesarean section. The most common indication found in most 
of the studies was post-term pregnancy. The risk of cesarean section varied from 3% to 48.7%. The common reasons for which the cesarean section 
was planned were, failed induction, nonprogress of labor, fetal distress, and undiagnosed CPD.
Conclusion: Most of the studies recommend induction of labor as a safer option with lower risk of c-section.
Keywords: Induction of labor, Indication of induction, Induction and c-section, Predictors of successful induction.
INTRODUCTION
The labor is a unique experience for the mother and she anxiously 
waits for the labor pain to come naturally. But when this fails to happen, 
she undergoes a procedure that artificially initiates the labor which 
is called induction of labor. The familiarity of the procedure is slowly 
rising in every setting from rural to well-equipped urban hospital. 
There is a demand in reducing the rate of unnecessary cesarean section 
and improvement of fetal outcomes. This is considered when delivery 
is thought to be the safer option than continuing the pregnancy [1]. 
Prostaglandins are lipids, found in cervical fluid, and decidua 
that reduce the inflammatory process and dilate the cervix [2,3]. 
Prostaglandine and its group of drugs when used for ripening of cervix 
in case of favorable or unfavorable cervix, was effective in bringing 
cervical favorability and with good progress of labor by successful 
induction with vaginal delivery within 24 hrs without much operative 
delivery [4-7]. The reasons for considering induction are many and 
vary from obstetrician to obstetrician and from country to country [8]. 
The most common indication that requires induction of labor is 
postdated pregnancy [9-22]. Another frequently cited indication is 
term premature rupture of membrane [12,13,23,24]. Nevertheless, the 
hypertensive disorder remains a rare indication, rather this requires 
induction in higher rate [14,20,21,25,26]. The less frequent indications 
are oligohydramnios, IUGR, gestational diabetes, fetal distress, 
macrosomia, fetal death, decreased fetal movement, uncomplicated 
twins, polyhydramnios, Rh isoimmunization, chorioamnionitis, heart 
disease, and other fetal indications [9-14]. In a meta-analysis, it is also 
observed that the common indications cited by many researchers are 
post-term pregnancy, PROM, oligohydramnios, twins, macrosomia, pre-
eclampsia, diabetes, and IUGR [23]. The outcomes of induction of labor 
are comparatively better than the spontaneous labor as reviewed from 
certain studies, while other studies found higher adverse outcomes 
associated with induction than the spontaneous labor. The causes for 
failure are mostly failed induction, fetal distress, undiagnosed CPD, 
meconeum stained liquor, nonprogress of labor, and prolonged latent 
phase [10-13,27,28].
METHODS
To collect a good number of quality studies with best recommendations, 
many electronic data bases were searched. The literature was collected 
from databases such as Pubmed, Scopus, Science Direct, and Google 
Scholar. The search was based on the keywords such as induction of 
labor, indication of induction, failed induction, induction in post-term 
pregnancy, induction in PROM, induction and risk of cesarean section 
and others. The literature was searched from the year 1995 onward. 
The literatures mostly included the studies which were systematic 
reviews, meta-analysis, randomized controlled trial (RCT), and cohort 
with strong recommendations. The indication of induction was studied 
from all kinds of scientific literatures those have specifically mentioned 
the indications. The studies on elective induction and studies on other 
methods of induction were excluded from the search.
RESULT
The literature was compiled in an ascending order, and a total of 
22 articles were analyzed for tabulating the indications for induction 
of labor. Table 1 shows the most frequent indications of induction in 
percentage.
The most common indication found by many authors is postdated 
pregnancy. Pregnancy when continues beyond 40 weeks is post-term 
pregnancy. About 7% of all pregnancies are post-term pregnancy [39]. 
Dean Leduce and Jarson Gardosi recorded postdates as highest 
indication for induction of labor [16,40]. Similarly, frequent indication 
for induction was postdates observed by Guerra et al. [10,26,41] Along 
with postdates, the hypertensive diseases of pregnancy are many times 
become the main indications for induction of labor [21]. Whereas 
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Chirwa found all three, hypertension (69.3%), PROM (15.0%), and 
postdated (12.6%) as common indications. Similarly, Sanchez-Ramos 
et al. observed 80% of indications for post-term pregnancies and rest 
for pregnancy induced hypertension and PROM [42]. Mozurkewich 
et al. and Abdul and Guerra et al. reported both postdated and PROM 
are the common indications for induction with high-quality evidence 
from various studies, whereas oligohydramnios was found with 
moderate evidence [26,43]. The induction of labor is commonly 
indicated in prevention of prolonged pregnancy, prelabor rupture 
of membranes after 34 weeks, intrauterine fetal death, placental 
abruption, chorioamnionitis, and hypertensive disorders as stated by 
NICE and ACOG [44,45]. Folasade and Oriyomi also recorded 25% of 
indications for postdates and 26% for premature rupture of labor [24]. 
Lawani et al. found the major indications as postdates (45.8%), term 
PROM (31.9%), pre-eclampsia (4.7%), and preterm PROM (3.7%) [13]. 
The common causes for which the induction were carried out in the 
United States were pre-eclampsia and postdates pregnancies and in few 
cases the premature rupture of membrane [46]. When the pregnancy 
over 41 weeks is induced, it is associated with fewer cesarean sections 
compared to expectant treatment [47]. Similarly, Mishanina et al. 
reported that the postdates pregnancy is associated with a reduced 
risk of cesarean delivery [48]. When labor was induced in term PROM, 
the rate of cesarean section remained almost same as the compared 
group [32]. However, the induction in pre-eclamptic group, studied by 
Xenakis et al. shows higher rate of cesarean section (Table 2) [49].
The data reviewed gives a conflicting picture that there is a trends 
toward decreased cesarean section with good cervical dilatation after 
misoprostol administration and the same time it is evident that there is 
an increased cesarean delivery for fetal distress and undiagnosed CPD. 
Many studies revealed that the prostaglandin and its group of drugs 
when used for ripening of cervix in case of favorable or unfavorable 
cervix, was effective in bringing cervical favorability, good progress of 
labor with a successful vaginal delivery within 24 hrs [34].
The rate of cesarean section was lowered by induction has been 
reported in many research studies. The successful vaginal delivery 
after induction was 70% [69], 75% [70], 89.1% [6]. Bueno et al. found 
that the vaginal delivery occurred in 73.5% of women in the induction 
group, and the rate of cesarean delivery was 26.5% [18]. Sahanaz et al. 
reported vaginal delivery of 78.9% and 21.1% of cesarean section after 
induction of labor [56,71]. However, Admani found in her study the 
success rate of 50% with similar rate of failure. The similar rate was 
observed in the study of Pravati et al. [33]. Bello and Akinyotu found 
induction failed with cesarean section in about 36.5% of women. 
Boulvain et al. demonstrated higher cesarean section with adverse 
perinatal outcomes after induction of labor [30].  Induced women had 
significantly higher cesarean rate than the spontaneous group [5,72]. 
However, Boulvain et al. did not get any clear risk of c-section after 
induction [73]. Sometime it was observed that there are no significant 
differences in CS rates between the groups of vaginal misoprostol or 
dinoprostone after induction [74]. In other instances, there is significant 
difference and it was found in CS rate between in the induction group 
and the spontaneous group both in nulliparous women (25.3% vs. 
8.6%, p<0.001) and multiparous women (3.8% vs. 0.3%, p=0.002) [10]. 
Similarly, the induction is associated with a significant increase in 
the risk of C-section than those who delivered spontaneously [59]. 
Boulvain et al. demonstrated higher cesarean section with adverse 
perinatal outcomes after induction of labor [30]. Clader reported little 
higher (28%) rate of cesarean section than the vaginal delivery (11%) 
after induction of labor with misoprostol [75]. However, many studies 
reported higher rate of vaginal delivery after induction (70% [69], 
75% [70], 89.1% [6]). The success rate for vaginal delivery was 
70% and this rate varied little in accordance with the country or the 
method used [58] Alfirevic et al. study revealed that though the vaginal 
prostaglandins increase the chance of uterine hyperstimulation but 
this increase the likelihood of vaginal birth within 24 hrs [76]. Whereas 
other studies shows the risk of cesarean delivery was 12% lower with 
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risk [RR] 0.88, 95% confidence interval [CI] 0.84-0.93; I2=0%) [48]. 
Wennerholm et al. also confirmed higher c-section by expectant 
management rather in the induction method [77]. The cesarean 
delivery rate in the induction group was 36.5% compared to 34.4% in 
the expectant management group [78]. Women undergoing induction 
of labor at 39 weeks without an acute obstetric medical indication were 
more likely to deliver vaginally than those managed expectantly [79]. 
Caughey found whether it is 37 or 39, there is no difference in cesarean 
section but at 40 and 41 weeks of gestation the women had a lower risk 
of cesarean delivery [80].
The reason of cesarean section is described by Pravati et al. as poor 
progress, fetal distress, cephalo-pelvic disproportion, oligohydramnios, 
and meconium staining [33]. Dr. Rashida found the reasons for cesarean 
Table 2: The rate and causes of cesarean section after induction and its’ predicting factors
Author Year Rate of 
c‑section (%)
Causes of cesarean section Predictors of cesarean section
Chirwa [25] 2014 17 Failed induction, fetal distress, CPD No misoprostol
Tolcher et al. [37] 2015 29.4 Nonreassuring heart rate Advanced age, short height, greater BMI, 
weight gain, hypertension, diabetes 
mellitus and initial cervical dilation <3 cm
Verhoeven et al. [22] 2013 3 Failure to progress and fetal distress History of preterm birth, maternal height 
and initial dilatation
Bueno et al. [18] 2007 26.5 Induction failure, nonreassuring fetal 
monitoring, pelvic disproportion, failure to 
progress
Cervical length, Bishop score and parity
Admani [10] 2014 32 Fetal distress, failed induction, nonprogress of 
labor and meconium stained liquor 
Favorable Bishop score and average-sized 
infants
Lee et al. [50] 2015 25.3 Induction failure Maternal age, BMI, Bishop score and parity
Park [51] 2007 14 Previous obstetric history, previous 
mid-trimester loss and preterm delivery
Earlier gestational age, previous obstetric 
history, and preterm delivery
Soni et al. [36] 2017 30.3 Failed induction, fetal distress, nonprogress of 
labor and undiagnosed CPD, malposition
Ezechi et al. [28] 2004 27.92 Cephalopelvic disproportion, fetal distress, 
prolong labor, and antepartum hemorrhage
Lawani et al. [13] 2014 24.1 Fetal distress, Prolonged labor, Cephalopelvic 
disproportion fetal distress, prolonged labor 
and cord prolapse
Jayaprakash et al. [52] 2016 8 Failed induction and fetal distress
Bello and Akinyotu [24] 2014 36.5 Higher parity, later gestation and 
misoprostol ripening
Khan et al. [27] 2015 18.1 Nulliparity, poor Bishop score and 
prolonged latent phage
Girma et al. [53] 2016 10.7 Bishop score, timing of induction and 
neonatal weight
Marroquin et al. [54] 2013 48.7 Younger age, lower BMI and lower 
maternal weight
Danielsen et al. [55] 2016 28.5 Bishop score, non-reassuring fetal status, 
failure to descend, malpresentation, 
abruption and worsening maternal 
medical status
Ahmadi et al. [56] 2016 21.1 Bishop score, parity and gestational age 
Parkes et al. [57] 2016 17.1 Intrauterine growth restriction, 
oligohydramnios, placental abruption, 
macrosomia and post-term pregnancy
Vahratian et al. [58] 2005 30 Unfavorable cervix
Davey and King [59] 2016 26.5 Use of analgesia, higher birth weight, older 
maternal age
Laughon et al. [60] 2011 Bishop score
Teixeira et al. [61] 2012 Bishop score
Mbele et al. [20] 2007 Primigravidity
Hurissa et al. [62] 2015 Advanced age, primiparity, unfavorable 
bishop score, premature rupture of 
membrane, greater for gestation and bad 
obstetric history
Hatfield et al. [15] 2007 Bishop score and parity
Grobman [63] 2015 Bishop score and parity
Crane [64] 2006 Maternal age, weight, height, BMI, 
gestational age, birth weight and amniotic 
fluid index
Ennen et al. [65] 2009 Drug doses and cervical dilatation
Pevnzer et al. [66] 2009 Drug doses and cervical dilatation
Ehrenthal et al. [67] 2010 Drug doses and cervical dilatation
Glantz [68] 2010 Drug doses and cervical dilatation
BMI: Body mass index
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as failed induction (52%), fetal distress (23%), and CPD (18%) [10]. 
Ezechi et al. reported the reasons for failed induction with misoprostol 
include cephalopelvic disproportion, fetal distress, prolong labor, and 
antepartum hemorrhage [28] Lawani et al. also described about fetal 
distress, prolonged labor, cephalopelvic disproportion as reasons for 
cesarean section [13]. From the study of Bueno et al., it is understood 
that the major reasons for cesarean delivery are induction failure 
(34%), nonreassuring fetal monitoring (28.9%), pelvic disproportion 
(17%), and failure to progress (14.9%) [18].
The major predicting factor for a successful vaginal delivery after 
induction is the cervical factor [20,43,52,55,60,61,81,82]. Teixeira et al. 
found in their meta-analysis, the Bishop score as greater determinant of 
successful induction [61]. Danielsen et al. stressed that a Bishop score 
of more than seven should be considered before induction as Bishop 
score is very good predictor of successful induction [55]. Vrouenraets 
et al. reported that a Bishop score of 5 or less is a significant risk factor 
for a cesarean delivery [83] Selo-Ojeme et al. viewed that regardless 
of membrane status, the CS rates were high in unfavorable cervix after 
induction of labor [84]. Dean Leduc highlighted that induction of labor 
among women with poor cervical dilatation is associated with higher 
rate of cesarean section [16]. Bello and Akinyotu found the predicting 
factors for risk of cesarean section are higher parity, later gestation and 
misoprostol ripening. Lee et al. observed the association of the higher 
CS rate with lower Bishop score, advanced maternal age, nulliparity 
and higher body mass index (BMI). Rashida reported the success rate 
induction with vaginal delivery that increased with increase of age. 
Rebecca Dekker found interestingly the rate is rising by age that is 29.5% in 
age 25-29 years to 33.0% in 30-34 years and 38.5% in 35-39 years and so 
on [85]. Rayamajhi et al. also noticed failure rate of 53.8% with advanced 
maternal age >30 years [31]. Gerli et al. also viewed that age is directly 
related to risk of cesarean section after a induction [86]. Hurissa et al. 
reported about the risk of cesarean section in association with advanced 
age, primiparity, unfavorable bishop score, later gestation, PROM, and bad 
obstetric history. The success was again related independently to cervical 
factors and parity [18]. Hatfield et al., Grobman, Tolcher et al. found older 
maternal age, shorter maternal height, greater BMI, greater weight gain 
during pregnancy, older gestational age, hypertension, diabetes mellitus, 
and initial cervical dilation as independent risk factors for increased risk 
of cesarean delivery [37,62,63]. Similarly, Crane reported the predictive 
factors as maternal age, weight, height, BMI, ethnicity, and socioeconomic 
status. Whereas Park found a single factor that is gestational age as 
a predictor of successful labor. Sometime the failed induction was 
dependent on drug doses and cervical dilatation [65-68]. Dublins 
reported increased cesarean delivery was associated with nulliparous 
rather than multiparous women with increased risk of instrumental 
delivery and shoulder dystocia [19]. Admani found higher rate of 
vaginal delivery in multipara than primipara. Lisa revealed that both 
the nulliparas (27%) and multiparas (13%) had an increased cesarean 
rate compared to spontaneous labor [87]. Compared to spontaneous 
onset of delivery, induction of labor is associated with an increased risk 
for emergency cesarean section among nulliparous and multiparous 
women [88] Alicia ault cited that the major risk associated with a failed 
induction at 39 weeks is cesarean delivery [89]. Park reported earlier 
gestational age as a significant predictive factor for failed IOL [51]. The 
highest chance of success was observed after induction of labor where 
there are prior vaginal delivery and favorable cervix [90] Timothy 
et al. in their systematic review found few reserearcher reporting about 
slower labors even after using higher doses of vaginal misoprostol [91] 
while other reported that high doses of oral or vaginal misoprostol are 
quite effective at achieving vaginal delivery. Pevzner et al. revealed that 
duration of labor, oxytocin requirements, and cesarean delivery rates 
are significantly higher with increasing BMI in prostaglandin-induced 
women (Table 3) [72].
The studies by meta-analysis, RCT and many other methods found 
different rate of risk of cesarean section at the end of the induction of 
labor. The risk of cesarean section depends on maternal factors such 
as age, parity, BMI, cervical score, baby size, medical, and obstetrical 
conditions complicating pregnancy. However, most of the studies 
found the induction is associated with more cervical ripening and 
successful vaginal delivery [6,14,69-70,76,98]. While few studies found 
the induction results in higher rate of cesarean delivery compared to 
expectant management [22,19,104].
Summary
This study tried to highlight various indications for which an induction 
of labor is decided for a woman. The common indications were post-
term pregnancy, term PROM, hypertensive disorders, intrauterine fetal 
distress, fetal death, gestational diabetes, and other fetal indications. 
Among these, the most common indication was postdated pregnancy. 
The failure of induction with cesarean section was varied from 3% to 
48.7%. However, most of the studies found higher rate of successful 
delivery after induction. The reason for which cesarean section was 
Table 3: The net outcome after induction of labor
Author Year Research design Net outcome (rate of cesarean section)
Mishanina et al. [48] 2014 Systematic review and meta-analysis Decreased
Hofmeyr and Gulmezoglu [92] 2001 Systematic review Decreased
Wood et al. [93] 2014 Meta-analysis Decreased
Gulmezoglu et al. [47] 2006 Systematic review Decreased
Gulmezoglu et al. [94] 2012 Systematic review Decreased
Sanchez Ramos et al. [29] 2003 Systematic review Decreased
Alfirevic et al. [76] 2014 Systematic review Decreased
Alfirevic et al. [95] 2000 Systematic review Decreased
Boulvain et al. [30] 2008 Systematic review Decreased
Vogel et al. [35] 2013 Systematic review Decreased
Crowley [96] 2000 Systematic review No difference
Boulvain et al. [73] 2016 Systematic review Not clear
Guerra et al. [26] 2009 Secondary analysis Decreased
Cheng [97] 2008 RCT Decreased
Koopmans et al. [98] 2009 RCT Decreased
Pennel et al. [99] 2009 RCT Increased
Bhutto et al. [100] 2013 RCT Nil
Hermus et al. [101] 2009 Cohort No difference
Marry et al. [37] 2015 Cohort Decreased
Yeast et al. [102] 1999 Cohort Decreased
Nooh et al. [103] 2005 Retrospective Decreased
Dubline et al. [19] 2000 Cohort Increased
Johnson et al. [104] 2003 Cohort Increased
Verhoeven et al. [22] 2012 Case control Increased
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done were failed induction, fetal distress, meconium stained liquor, 
undiagnosed CPD, and nonprogress of labor. The factors independently 
predicted the risk of cesarean section were age of mother, parity, BMI, 
cervical factors, indications, doses of drug and weight of baby. Most 
of the systematic reviews showed decreased rate of c-section after 
induction in term pregnancy. Hence, it is clear from the findings that 
induction of labor is beneficial in reducing the risk of cesarean section 
with better perinatal outcomes.
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